Science Explorer Back to mapMap
Discussion
Company · Kifissia · Greece

Uni Pharma (Greece)

Research works
14
▲ 49% vs 2018-21
Citations
151
11.1 per fractional work
Top-10% rate
26.5%
all institutions 10.0%
Open access
76%
world 40%
International
25%
world 18%

Not ranked overall: Uni Pharma (Greece) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Uni Pharma (Greece) work in?

In all years, 64% of research at Uni Pharma (Greece) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (56%), Biochemistry, Genetics and Molecular Biology (13%), Nursing (8%). It does 1.9× the world's share of Health Sciences.

Health Sciences: 9 fractional works · 64.2% of its workMedicine: 8 fractional works · 56.2% of its workSurgery: 1 fractional works · 6.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 6.1% of its workInfectious Diseases: 1 fractional works · 5.4% of its workOncology: 1 fractional works · 4.3% of its workPharmacology: 0 fractional works · 3.7% of its workPathology and Forensic Medicine: 0 fractional works · 3.4% of its workDermatology: 0 fractional works · 3.4% of its workOrthopedics and Sports Medicine: 0 fractional works · 3.1% of its workRehabilitation: 0 fractional works · 2.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 2.4% of its workRheumatology: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 1.6% of its workHematology: 0 fractional works · 1.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.6% of its workComplementary and alternative medicine: 0 fractional works · 1.2% of its workUrology: 0 fractional works · 1.2% of its workPhysiology: 0 fractional works · 1.1% of its workImmunology and Allergy: 0 fractional works · 1.0% of its workNephrology: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.4% of its workEmergency Medicine: 0 fractional works · 0.4% of its workAnesthesiology and Pain Medicine: 0 fractional works · 0.4% of its workEpidemiology: 0 fractional works · 0.4% of its workOphthalmology: 0 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.4% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.4% of its workGastroenterology: 0 fractional works · 0.3% of its workNursing: 1 fractional works · 8.1% of its workNutrition and Dietetics: 1 fractional works · 8.1% of its workLife Sciences: 4 fractional works · 25.6% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 12.8% of its workMolecular Biology: 1 fractional works · 6.2% of its workBiochemistry: 1 fractional works · 5.5% of its workGenetics: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 1 fractional works · 6.1% of its workPlant Science: 0 fractional works · 2.4% of its workFood Science: 0 fractional works · 2.3% of its workInsect Science: 0 fractional works · 1.4% of its workImmunology and Microbiology: 0 fractional works · 3.2% of its workImmunology: 0 fractional works · 2.6% of its workMicrobiology: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 2.1% of its workPharmacology: 0 fractional works · 1.2% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workNeuroscience: 0 fractional works · 1.5% of its workDevelopmental Neuroscience: 0 fractional works · 0.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.4% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workPhysical Sciences: 1 fractional works · 7.3% of its workChemistry: 1 fractional works · 3.7% of its workOrganic Chemistry: 1 fractional works · 3.7% of its workEngineering: 0 fractional works · 1.2% of its workBiomedical Engineering: 0 fractional works · 1.2% of its workMaterials Science: 0 fractional works · 1.2% of its workBiomaterials: 0 fractional works · 1.2% of its workMathematics: 0 fractional works · 1.1% of its workModeling and Simulation: 0 fractional works · 1.1% of its workSocial Sciences: 0 fractional works · 2.8% of its workPsychology: 0 fractional works · 2.8% of its workClinical Psychology: 0 fractional works · 2.4% of its workSocial Psychology: 0 fractional works · 0.4% of its workALL ITS WORKUni Pharma(Greece)14fractional works, all years
Life Sciences26%Physical Sciences7%Health Sciences64%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Medicine856.2%
    2. Nursing18.1%
    1. Biochemistry, Genetics and Molecular Biology212.8%
    2. Agricultural and Biological Sciences16.1%
    3. Immunology and Microbiology03.2%
    4. Pharmacology, Toxicology and Pharmaceutics02.1%
    5. Neuroscience01.5%
    1. Chemistry13.7%
    2. Engineering01.2%
    3. Materials Science01.2%
    4. Mathematics01.1%
    1. Psychology02.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 2.01× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.59× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 6.15× its world share, 0 worksImmunology and Micro…Neuroscience: 0.91× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.04× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.02× its world share, 0 worksChemistryEngineering: 0.16× its world share, 0 worksEngineeringMaterials Science: 0.68× its world share, 0 worksMaterials ScienceMathematics: 1.83× its world share, 0 worksMathematicsMedicine: 2.45× its world share, 3 worksMedicineNursing: 8.54× its world share, 0 worksNursingPsychology: 0.22× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 9.0×. Every wedge is a field page.

All 12 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.04×0 works
  2. Nursing8.54×0 works
  3. Immunology and Microbiology6.15×0 works
  4. Biochemistry, Genetics and Molecular Biology3.59×1 works
  5. Medicine2.45×3 works
  6. Agricultural and Biological Sciences2.01×1 works
  7. Mathematics1.83×0 works
  8. Chemistry1.02×0 works
  9. Neuroscience0.91×0 works
  10. Materials Science0.68×0 works
  11. Psychology0.22×0 works
  12. Engineering0.16×0 works

What are the most cited papers from Uni Pharma (Greece)?

The most cited paper from Uni Pharma (Greece) is "A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates" (Nikolaos Viazis, Konstantinos Argyriou, Katerina E. Kotzampassi et al., 2022), with 92 citations. Next come "Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms" (76) and "Saffron ( Crocus sativus ) intake provides nutritional preconditioning against myocardial ischemia–reperfusion injury in Wild Type and ApoE (−/−) mice: Involvement of Nrf2 activation" (37).

Most cited papers
#PaperReleasedCitations
1 A Four-Probiotics Regimen Combined with A Standard Helicobacter pylori-Eradication Treatment Reduces Side Effects and Increases Eradication Rates Nikolaos Viazis, Konstantinos Argyriou, Katerina E. Kotzampassi et al. · Nutrients Open access Feb 2022 92
2 Lyotropic Liquid Crystalline Nanostructures as Drug Delivery Systems and Vaccine Platforms Maria Chountoulesi, Stergios Pispas, Ioulia K. Tseti et al. · Pharmaceuticals Open access 31 Mar 2022 76
3 Saffron ( Crocus sativus ) intake provides nutritional preconditioning against myocardial ischemia–reperfusion injury in Wild Type and ApoE (−/−) mice: Involvement of Nrf2 activation Panagiotis Efentakis, Anna Rizakou, Eirini Christodoulou et al. · Nutrition Metabolism and Cardiovascular Diseases 31 Aug 2017 37
4 Effect of Long-Term Hydroxytyrosol Administration on Body Weight, Fat Mass and Urine Metabolomics: A Randomized Double-Blind Prospective Human Study Christina I. Fytili, Theodora Nikou, Nikolaοs Tentolouris et al. · Nutrients Open access 6 Apr 2022 36
5 Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study Vasiliki-Kalliopi Bournia, George E. Fragoulis, Panagiota Mitrou et al. · Lara D. Veeken Open access 3 Aug 2022 35
All 46 most cited papers, with filters and sorting

Which research topics does Uni Pharma (Greece) publish most on?

By volume in 2022-now: Eicosanoids and Hypertension Pharmacology, Wound Healing and Treatments, Probiotics and Fermented Foods and Fatty Acid Research and Health.

  1. 1 Eicosanoids and Hypertension Pharmacology Biochemistry 0 works
  2. 2 Wound Healing and Treatments Rehabilitation 0 works
  3. 3 Probiotics and Fermented Foods Food Science 0 works
  4. 4 Fatty Acid Research and Health Nutrition and Dietetics 0 works
  5. 5 Electrospun Nanofibers in Biomedical Applications Biomaterials 0 works
  6. 6 Bone Tissue Engineering Materials Biomedical Engineering 0 works
  7. 7 Periodontal Regeneration and Treatments Urology 0 works
  8. 8 Bee Products Chemical Analysis Insect Science 0 works
  9. 9 Rheumatoid Arthritis Research and Therapies Rheumatology 0 works
  10. 10 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available75.8%not open24.2%

World: 40% of research is openly available.

with international co-authors24.9%domestic only75.1%

World: 18% is written across borders.

How has Uni Pharma (Greece)'s research output changed?

Output in 2022-2025 was 49% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Uni Pharma (Greece) as a percentage of every work published that year, 0.000025% in 2024.

still counting0.000020%0.000040%0.000060%Uni Pharma (Greece)0.000012% in 202520102020

Fractional works of Uni Pharma (Greece) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Kifissia

All research institutions in Kifissia

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Uni Pharma (Greece). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.